Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.740
0.00 (0.00%)
Sep 5, 2025, 4:00 PM - Market closed
Pulmonx Employees
Pulmonx had 291 employees as of December 31, 2024. The number of employees increased by 12 or 4.30% compared to the previous year.
Employees
291
Change (1Y)
12
Growth (1Y)
4.30%
Revenue / Employee
$311,165
Profits / Employee
-$195,670
Market Cap
70.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 291 | 12 | 4.30% |
| Dec 31, 2023 | 279 | 10 | 3.72% |
| Dec 31, 2022 | 269 | 16 | 6.32% |
| Dec 31, 2021 | 253 | 33 | 15.00% |
| Dec 31, 2020 | 220 | 40 | 22.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LUNG News
- 11 days ago - Pulmonx to Participate in September Investor Conferences - GlobeNewsWire
- 5 weeks ago - Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Pulmonx Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025 - GlobeNewsWire
- 3 months ago - Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference - GlobeNewsWire
- 4 months ago - Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Pulmonx Reports First Quarter 2025 Financial Results - GlobeNewsWire